Biosplice Therapeutics

United States · 60 Employees
Biosplice is developing first-in-class, small-molecule therapeutics based on pioneering science of alternative pre-mRNA splicing. Stemming from foundational discoveries in Wnt pathway modulation, Biosplice has elucidated novel biology linking CLK/DYRK kinases to the therapeutic regulation of alternative splicing. Alternative splicing is an essential biological mechanism that regulates the diversification of proteins in a cell, which, in turn, determines cell type and function. Biosplice's target class governs the selection of tissue-specific mRNA splice sites, making them attractive, druggable targets within the cellular "command and control" center. Biosplice's drugs in clinical development include lorecivivint for osteoarthritis (in Phase 3), cirtuvivint for numerous cancers, and a broad pipeline that ranges from Alzheimer's disease to other degenerative conditions. Learn more at https://www.biosplice.com

概述

国家 United States
成立时间 2008
总部 9360 towne centre drive, san diego, california, united states
电话号码 +1 858 926 2900
网站 http://www.biosplice.com
LinkedIn http://www.linkedin.com/company/biospliceinc
Twitter
Facebook
员工数 60
行业 biotechnology,
简介 Biosplice is developing first-in-class, small-molecule therapeutics based on pioneering science of alternative pre-mRNA splicing. Stemming from foundational discoveries in Wnt pathway modulation, Biosplice has elucidated novel biology linking CLK/DYRK kinases to the therapeutic regulation of alternative splicing. Alternative splicing is an essential biological mechanism that regulates the diversification of proteins in a cell, which, in turn, determines cell type and function. Biosplice's target class governs the selection of tissue-specific mRNA splice sites, making them attractive, druggable targets within the cellular "command and control" center. Biosplice's drugs in clinical development include lorecivivint for osteoarthritis (in Phase 3), cirtuvivint for numerous cancers, and a broad pipeline that ranges from Alzheimer's disease to other degenerative conditions. Learn more at https://www.biosplice.com

技术

ASP.NET

Frameworks and Programming Languages

Google Analytics

Analytics and Tracking

Google Tag Manager

Tag Management

Microsoft Azure Hosting

Hosting

Microsoft Office 365

Other

Mobile Friendly

Other

Outlook

Email Providers

StatCounter

Analytics and Tracking

常见问题

Biosplice Therapeutics 在哪里?

Biosplice Therapeutics 的总部位于 9360 towne centre drive, san diego, california, united states

Biosplice Therapeutics 的电话号码是多少?

Biosplice Therapeutics 的电话号码是 +1 858 926 2900

Biosplice Therapeutics 的官方网站是什么?

Biosplice Therapeutics 的公司官方网站是 http://www.biosplice.com

Biosplice Therapeutics 是做什么的?

Biosplice Therapeutics 的业务有哪些?

Biosplice Therapeutics 的年收入是多少?

Biosplice Therapeutics 的收入是 4000000美元

Biosplice Therapeutics 有多少员工?

Biosplice Therapeutics 有 60 名员工

Biosplice Therapeutics 属于哪个行业?

Biosplice Therapeutics 从事以下行业: biotechnology

Biosplice Therapeutics 使用什么技术?

Biosplice Therapeutics 使用的一些流行技术包括: ASP.NET,Google Analytics,Google Tag Manager,Microsoft Azure Hosting,Microsoft Office 365,Mobile Friendly,Outlook,StatCounter

如何联系 Biosplice Therapeutics?

Biosplice Therapeutics 联系信息: 电话号码:+1 858 926 2900, 网站:http://www.biosplice.com, 邮箱:ros***@***.com

Biosplice Therapeutics 的社交媒体链接是什么?

Biosplice Therapeutics 领英:http://www.linkedin.com/company/biospliceinc,fackbook:,twitte:

Biosplice Therapeutics 是一家上市公司吗?

不是

Biosplice Therapeutics 的最后一轮融资是什么时候?

Biosplice Therapeutics在2021-04-01T00:00:00.000+00:00结束了最后一轮融资,金额达120M$。

谁投资 Biosplice Therapeutics?

Biosplice Therapeutics 有 2 家投资者,包括 Eventide Asset Management, aMoon, Sands Capital, Verition Fund Management、Vickers Venture Partners。

管理层

Rose Hammack

Associate Director Clinical Operations

Carine Bossard

Director, Tumor Biology

Jon B

Senior Manager, Biometrics

Chad Atlas

Vice President, Deputy General Counsel

Mirta Grifman

Vice President, Clinical Development and External Innovation

员工

Scott Bulcao

Chief Legal Officer

Regina Beavers

Programmer Analyst II

Lewis Turner

Scientist III, Chemistry

David Benardo

Research Associate III Compound Management

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google